These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33820859)

  • 1. Interobserver Agreement in the Diagnosis of Parkinson Disease with Cardiac
    Foley RW; Redman SL; Laurence IJ; Graham RN; Little D
    J Nucl Med Technol; 2021 Sep; 49(3):262-264. PubMed ID: 33820859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.
    Matsuo S; Nakajima K; Okuda K; Kawano M; Ishikawa T; Hosoya T; Taki J; Kinuya S
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):560-6. PubMed ID: 18989667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of low- and medium-energy collimators in 123I-MIBG myocardial scintigraphy].
    Sakashita R; Sugimoto K; Fukuya Y; Fujibuchi H; Ishida T; Higashimura K; Tsuchida T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 Feb; 63(2):241-6. PubMed ID: 17387245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septal penetration in iodine-123 metaiodobenzylguanidine cardiac sympathetic imaging using a medium-energy collimator.
    Inoue Y; Abe Y; Asano Y; Kikuchi K; Iizuka T; Nishiyama K
    J Nucl Cardiol; 2014 Feb; 21(1):71-7. PubMed ID: 24150537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.
    Oh JK; Choi EK; Song IU; Kim JS; Chung YA
    J Neural Transm (Vienna); 2015 Oct; 122(10):1421-7. PubMed ID: 26003179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Nuvoli S; Spanu A; Fravolini ML; Bianconi F; Cascianelli S; Madeddu G; Palumbo B
    Mol Imaging Biol; 2020 Jun; 22(3):703-710. PubMed ID: 31309370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of collimator-dependent differences in the heart-to-mediastinum ratio in
    Inoue Y; Abe Y; Kikuchi K; Matsunaga K; Masuda R; Nishiyama K
    J Nucl Cardiol; 2017 Oct; 24(5):1725-1736. PubMed ID: 27251143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging.
    Inoue Y; Abe Y; Itoh Y; Asano Y; Kikuchi K; Sakamoto Y; Matsunaga K; Ogino Y; Iizuka T; Mochizuki H
    J Nucl Med; 2013 May; 54(5):707-13. PubMed ID: 23536225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
    Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac 123I-MIBG scintigraphy in patients with essential tremor.
    Lee PH; Kim JW; Bang OY; Joo IS; Yoon SN; Huh K
    Mov Disord; 2006 Aug; 21(8):1235-8. PubMed ID: 16671077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
    Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
    Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
    Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.
    Veltman CE; Boogers MJ; Meinardi JE; Al Younis I; Dibbets-Schneider P; Van der Wall EE; Bax JJ; Scholte AJ
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1599-608. PubMed ID: 22790878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [123I-metaiodobenzylguanidine myocardial scintigraphy in a case of pheochromocytoma before and after resection of it].
    Matsumoto K; Sugihara H; Ito K; Terada K; Taniguchi Y; Ohtsuki K; Nakata T; Ushijima Y; Maeda T; Nakagawa M
    Kaku Igaku; 1995 Sep; 32(9):1023-8. PubMed ID: 8523838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.
    Inoue Y; Abe Y; Asano Y; Kikuchi K; Matsunaga K; Iizuka T; Nishiyama K
    J Nucl Cardiol; 2014 Jun; 21(3):614-21. PubMed ID: 24715623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.